Literature DB >> 22220582

Endothelial actions of atrial and B-type natriuretic peptides.

Michaela Kuhn1.   

Abstract

The cardiac hormone atrial natriuretic peptide (ANP) is critically involved in the maintenance of arterial blood pressure and intravascular volume homeostasis. Its cGMP-producing GC-A receptor is densely expressed in the microvascular endothelium of the lung and systemic circulation, but the functional relevance is controversial. Some studies reported that ANP stimulates endothelial cell permeability, whereas others described that the peptide attenuates endothelial barrier dysfunction provoked by inflammatory agents such as thrombin or histamine. Many studies in vitro addressed the effects of ANP on endothelial proliferation and migration. Again, both pro- and anti-angiogenic properties were described. To unravel the role of the endothelial actions of ANP in vivo, we inactivated the murine GC-A gene selectively in endothelial cells by homologous loxP/Cre-mediated recombination. Our studies in these mice indicate that ANP, via endothelial GC-A, increases endothelial albumin permeability in the microcirculation of the skin and skeletal muscle. This effect is critically involved in the endocrine hypovolaemic, hypotensive actions of the cardiac hormone. On the other hand the homologous GC-A-activating B-type NP (BNP), which is produced by cardiac myocytes and many other cell types in response to stressors such as hypoxia, possibly exerts more paracrine than endocrine actions. For instance, within the ischaemic skeletal muscle BNP released from activated satellite cells can improve the regeneration of neighbouring endothelia. This review will focus on recent advancements in our understanding of endothelial NP/GC-A signalling in the pulmonary versus systemic circulation. It will discuss possible mechanisms accounting for the discrepant observations made for the endothelial actions of this hormone-receptor system and distinguish between (patho)physiological and pharmacological actions. Lastly it will emphasize the potential therapeutical implications derived from the actions of NPs on endothelial permeability and regeneration.
© 2012 The Author. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22220582      PMCID: PMC3417485          DOI: 10.1111/j.1476-5381.2012.01827.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  94 in total

Review 1.  Regulation of endothelial permeability via paracellular and transcellular transport pathways.

Authors:  Yulia Komarova; Asrar B Malik
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

2.  Effect of atriopeptin III on hematocrit and volemia of nephrectomized rats.

Authors:  J P Flückiger; B Waeber; G Matsueda; B Delaloye; J Nussberger; H R Brunner
Journal:  Am J Physiol       Date:  1986-10

3.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

Authors:  A J de Bold; H B Borenstein; A T Veress; H Sonnenberg
Journal:  Life Sci       Date:  1981-01-05       Impact factor: 5.037

4.  Lung endothelial dysfunction in congestive heart failure: role of impaired Ca2+ signaling and cytoskeletal reorganization.

Authors:  Alexander Kerem; Jun Yin; Stephanie M Kaestle; Julia Hoffmann; Axel M Schoene; Baljit Singh; Hermann Kuppe; Mathias M Borst; Wolfgang M Kuebler
Journal:  Circ Res       Date:  2010-02-18       Impact factor: 17.367

5.  Effectiveness of human atrial natriuretic peptide supplementation in pulmonary edema patients using the pulse contour cardiac output system.

Authors:  Yuichiro Sakamoto; Kunihiro Mashiko; Nobuyuki Saito; Hisashi Matsumoto; Yoshiaki Hara; Noriyoshi Kutsukata; Hiroyuki Yokota
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

6.  ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFalpha.

Authors:  Junjie Xing; Anna A Birukova
Journal:  Microvasc Res       Date:  2009-11-26       Impact factor: 3.514

7.  Atrial natriuretic peptide modulation of albumin clearance and contrast agent permeability in mouse skeletal muscle and skin: role in regulation of plasma volume.

Authors:  Fitz-Roy E Curry; Cecilie Brekke Rygh; Tine Karlsen; Helge Wiig; Roger H Adamson; Joyce F Clark; Yueh-Chen Lin; Birgit Gassner; Frits Thorsen; Ingrid Moen; Olav Tenstad; Michaela Kuhn; Rolf K Reed
Journal:  J Physiol       Date:  2009-11-30       Impact factor: 5.182

8.  Hypervolemic hypertension in mice with systemic inactivation of the (floxed) guanylyl cyclase-A gene by alphaMHC-Cre-mediated recombination.

Authors:  Boris V Skryabin; Rita Holtwick; Larissa Fabritz; Markus N Kruse; Ilka Veltrup; Jörg Stypmann; Paulus Kirchhof; Karim Sabrane; Alexander Bubikat; Melanie Voss; Michaela Kuhn
Journal:  Genesis       Date:  2004-08       Impact factor: 2.487

9.  Atrial natriuretic factor decreases whole-body capillary absorption in rats.

Authors:  N C Trippodo; R W Barbee
Journal:  Am J Physiol       Date:  1987-05

10.  Atrial natriuretic factor increases hematocrit and decreases plasma volume in nephrectomized rats.

Authors:  F A Almeida; M Suzuki; T Maack
Journal:  Life Sci       Date:  1986-09-29       Impact factor: 5.037

View more
  34 in total

1.  Intersectin-1s: an important regulator of cellular and molecular pathways in lung injury.

Authors:  Dan N Predescu; Cristina Bardita; Rajive Tandon; Sanda A Predescu
Journal:  Pulm Circ       Date:  2013-12-05       Impact factor: 3.017

2.  Changes of adrenomedullin and natriuretic peptides in patients with adrenal medullary hyperplasia prior to and following pharmacological therapy and adrenalectomy.

Authors:  Pang-Hu Zhou; Lei Shi; Wei Hu; Xiao-Bin Zhang; Wei Wang; Li-Jun Zhang
Journal:  Exp Ther Med       Date:  2016-06-03       Impact factor: 2.447

3.  Plasma concentrations of adrenomedullin and atrial and brain natriuretic peptides in patients with adrenal pheochromocytoma.

Authors:  Wei Hu; Lei Shi; Pang-Hu Zhou; Xiao-Bin Zhang
Journal:  Oncol Lett       Date:  2015-09-02       Impact factor: 2.967

4.  The role of cGMP/cGKI signalling and Trpc channels in regulation of vascular tone.

Authors:  Florian Loga; Katrin Domes; Marc Freichel; Veit Flockerzi; Alexander Dietrich; Lutz Birnbaumer; Franz Hofmann; Jörg W Wegener
Journal:  Cardiovasc Res       Date:  2013-07-04       Impact factor: 10.787

5.  C-type natriuretic peptide inhibiting vascular calcification might involve decreasing bone morphogenic protein 2 and osteopontin levels.

Authors:  Jing-Jing Chen; Jing Zhang; Yan Cai; Ye-Bo Zhou; Ge-Bo Wen; Chao-Shu Tang; Yong-Fen Qi; Zhi-Sheng Jiang
Journal:  Mol Cell Biochem       Date:  2014-04-08       Impact factor: 3.396

6.  Atrial natriuretic peptide down-regulates LPS/ATP-mediated IL-1β release by inhibiting NF-kB, NLRP3 inflammasome and caspase-1 activation in THP-1 cells.

Authors:  Letizia Mezzasoma; Cinzia Antognelli; Vincenzo Nicola Talesa
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

7.  Atrial natriuretic peptide down-regulates neutrophil recruitment on inflamed endothelium by reducing cell deformability and resistance to detachment force.

Authors:  Vasilios A Morikis; Chris Radecke; Yanyan Jiang; Volkmar Heinrich; Fitz-Roy Curry; Scott I Simon
Journal:  Biorheology       Date:  2015       Impact factor: 1.875

Review 8.  Protection of kidney function and tissue integrity by pharmacologic use of natriuretic peptides and neprilysin inhibitors.

Authors:  Juan Brignone; Kasper Bostlund Assersen; Mia Jensen; Boye L Jensen; Brian Kloster; Morten Jønler; Lars Lund
Journal:  Pflugers Arch       Date:  2021-04-12       Impact factor: 3.657

9.  An extensive DeBakey type IIIb aortic dissection with massive right pleural effusion presenting as abdominal pain and acute anemia: particular case report.

Authors:  Hui-Chun Yu; Zhen-Qing Wang; Yuan-Yuan Hao; Feng-Ping An; Yu-Chuan Hu; Rui-Bing Deng; Peng Yu; Guang-Bin Cui; He Li
Journal:  J Geriatr Cardiol       Date:  2015-05       Impact factor: 3.327

Review 10.  DPP4 in Diabetes.

Authors:  Diana Röhrborn; Nina Wronkowitz; Juergen Eckel
Journal:  Front Immunol       Date:  2015-07-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.